Titan America SA Common Shares (TTAM)
13.83
-0.09 (-0.68%)
NYSE · Last Trade: Jun 11th, 11:48 AM EDT

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025